Detalles de la búsqueda
1.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208843
2.
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Clin Gastroenterol Hepatol
; 20(5): 1151-1162.e6, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34333150
3.
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
J Formos Med Assoc
; 121(8): 1567-1578, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123849
4.
Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan.
Am J Kidney Dis
; 78(4): 511-519.e1, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33940114
5.
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Liver Int
; 41(6): 1265-1277, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33655714
6.
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
J Gastroenterol Hepatol
; 36(10): 2884-2892, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963615
7.
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.
J Gastroenterol Hepatol
; 36(8): 2247-2254, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33624849
8.
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Am J Gastroenterol
; 115(8): 1226-1235, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32221162
9.
Endosonography for suspected obstructive jaundice with no definite pathology on ultrasonography.
J Formos Med Assoc
; 114(9): 820-8, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24090635
10.
Endosonography for Pancreatic Duct Dilatation without Definite Pathology on Ultrasonography.
Hepatogastroenterology
; 61(131): 842-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26176084
11.
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.
Infect Dis Ther
; 13(6): 1199-1213, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38679663
12.
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan.
Hepatol Int
; 18(2): 461-475, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246899
13.
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Clin Mol Hepatol
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637957
14.
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
Clin Mol Hepatol
; 30(1): 64-79, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38195113
15.
For biliary dilatation, a negative endosonography needs additional image studies in weight loss suggesting malignancy.
Dig Dis Sci
; 58(8): 2345-52, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23546699
16.
A new collaborative care approach toward hepatitis C elimination in marginalized populations.
J Infect Public Health
; 16(8): 1201-1208, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271101
17.
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Hepatol Int
; 17(3): 550-561, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36973633
18.
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.
Viruses
; 14(2)2022 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35215926
19.
Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study.
Am J Cancer Res
; 12(7): 3164-3174, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35968345
20.
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan.
Infect Dis Ther
; 11(1): 485-500, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34967920